Researchers have made a new discovery in mice that may allow patients with acute myeloid leukemia to be spared from toxic treatments, while also opening the door to new therapies. The new study has identified a number of specific gene mutations that correlate with prognosis and treatment response.
An estimated 3,500 women in the United States receive a diagnosis of cancer during pregnancy each year. Each woman in this situation is faced with a dilemma: delaying her treatment may risk her life, but proceeding with therapy may risk harming her unborn child.
A new review of targeted therapies’ and immunotherapies’ adverse effects on the thyroid gland, including recommendations for screening and treatment, has been published. The study reported that the therapies are linked to thyroid dysfunction in 20%–50% of patients, which can result in adverse effects on patients’ quality of life.
It has long been known that being overweight or obese is associated with an increased risk for many types of cancer, including postmenopausal breast, endometrial, colorectal, esophageal, gallbladder, kidney, pancreatic, and thyroid cancer. The questions is, why? What is the process through which excess weight increases cancer risk?
Men with newly diagnosed, low-risk prostate cancer face difficult decisions about treatment. Options include radical prostatectomy, external beam radiotherapy (EBRT), or brachytherapy, all of which provide high rates of disease control but are associated with quality of life (QOL) complications, such as erectile dysfunction. A new tool may help patients predict the risk of this impairment.